13 completed, 8 unknown, 4 withdrawn, 2 not yet recruiting. 18 Not applicable, 4 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 18 | Completed 10, Unknown 5, Recruiting 2, Withdrawn 1 |
| Phase 2 | 4 | Withdrawn 3, Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Continuous glucose monitoring system: new trials by email Literature Review of Continuous glucose monitoring system trials Research Report on Continuous glucose monitoring system
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis Continuous glucose monitoring system - Continuous Glucose Monitoring, ESRD (End-Stage Renal Disease) | Not yet recruiting | Elaine Chow | 100 | 2026-08-31 | 2026-08-27 | |
| ROME GS System Study Continuous Glucose Monitoring System - Diabetes, Diabetes Melletus, Type 1 | Not applicable | Recruiting | Senseonics, Inc. | 60 | 2026-02-12 | 2026-04-21 |
| Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature Continuous Glucose Monitoring System - Diabetes Mellitus, Diabetes Mellitus, Type 1 | Not applicable | Recruiting | Senseonics, Inc. | 80 | 2025-12-29 | 2026-04-21 |
| CGM in Icodextrin PD Continuous glucose monitoring system - Diabetes Mellitus (Diagnosis), End Stage Renal Disease (ESRD) | Not yet recruiting | Elaine Chow | 30 | 2025-02-20 | 2025-02-21 | |
| Characterization of the "Transfusion-dependent Prediabetes" Using Continuous Glucose Monitoring Continuous glucose monitoring system - Prediabetic State | Not applicable | Completed | University of Campania Luigi Vanvitelli | 29 | 2023-07-01 | 2024-08-06 |
| Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome continuous glucose monitoring system, capillary blood glucose monitoring - Type 2 Diabetes Mellitus, Acute Coronary Syndrome | Not applicable | Unknown | Ningbo No. 1 Hospital | 100 | 2022-06-01 | 2022-05-25 |
| Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features Continuous Glucose Monitoring System - Diabetes Mellitus, Diabetes Mellitus, Type 1 | Not applicable | Unknown | Senseonics, Inc. | 350 | 2021-10-20 | 2023-04-26 |
| Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting Continuous Glucose Monitoring System - Patients Needing Glucose Control | Not applicable | Unknown | DexCom, Inc. | 250 | 2021-06-01 | 2021-05-10 |
| Physical Inactivity Impacts on Blood Vessel Health and Glucose Levels in an Aging Population Continuous Glucose Monitoring System - Aging, Cardiovascular Diseases | Not applicable | Completed | Leryn Reynolds | 20 | 2021-04-01 | 2026-03-04 |
| Evaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis Continuous glucose monitoring system - Diabetes Mellitus (Diagnosis), End Stage Renal Disease | Completed | Elaine Chow | 30 | 2021-03-01 | 2022-11-28 | |
| Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System Continuous Glucose Monitoring System - Diabetes Mellitus | Not applicable | Unknown | DexCom, Inc. | 150 | 2020-10-12 | 2020-11-27 |
| Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels Single-hormone closed-loop system, Insulin pump, Continuous glucose monitoring system - Type 1 Diabetes | Not applicable | Completed | Institut de Recherches Cliniques de Montreal | 30 | 2020-07-10 | 2022-01-28 |
| Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform continuous glucose monitoring system - PreDiabetes, Glucose Metabolism Disorders | Completed | Pusan National University Hospital | 130 | 2020-05-11 | 2022-05-09 | |
| The Effect of Continuous Glucose Monitoring on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes Mellitus Continuous Glucose Monitoring System - Gestational Diabetes, Continuous Glucose Monitoring | Phase 4 | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 154 | 2019-04-01 | 2019-05-20 |
| Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes 12-day intervention with sensor-augmented pump therapy, 12-day intervention with single-hormone closed-loop strategy, Insulin pump - Type 1 Diabetes | Phase 2 | Completed | Institut de Recherches Cliniques de Montreal | 36 | 2019-01-24 | 2020-06-11 |
| PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days Continuous Glucose Monitoring System - Diabetes Mellitus, Diabetes Mellitus, Type 1 | Not applicable | Completed | Senseonics, Inc. | 208 | 2018-12-27 | 2024-08-20 |
| Relationship Between Blood Glucose Variability and Prognosis in Critically Ill Patients Continuous Glucose Monitoring System - Diabetes | Unknown | Nanjing First Hospital, Nanjing Medical University | 200 | 2018-08-03 | 2018-08-14 | |
| The Blood Glucose Control in Patients With Type 2 Diabetes Treated With Glargine Continuous Glucose Monitoring System - Type2 Diabetes | Unknown | Nanjing First Hospital, Nanjing Medical University | 100 | 2018-06-12 | 2019-06-11 | |
| Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels Insulin pump, Continuous glucose monitoring system, 11-hour intervention with the single-hormone artificial pancreas - Type 1 Diabetes Mellitus | Phase 2 | Withdrawn | Institut de Recherches Cliniques de Montreal | 2018-04-01 | 2018-04-27 | |
| Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes 5-day intervention with single-hormone closed-loop strategy, 5-day intervention with sensor-augmented pump therapy, Insulin pump - Type 1 Diabetes | Phase 2 | Withdrawn | Institut de Recherches Cliniques de Montreal | 2018-03-01 | 2018-01-31 |
Showing 20 of 29. Sign in to see all of them.
Diabetes Mellitus (16) · Diabetes Mellitus, Type 1 (10) · Diabetes Mellitus, Type 2 (7) · Insulin Resistance (5) · Hypoglycemia (3) · Diabetes, Gestational (2) · Disease (2) · Kidney Failure, Chronic (2) · Prediabetic State (2) · Acute Coronary Syndrome (1) · Cardiovascular Diseases (1) · Glucose Intolerance (1) · Glucose Metabolism Disorders (1) · Motor Activity (1) · Renal Insufficiency, Chronic (1)
Senseonics, Inc. (7) · Institut de Recherches Cliniques de Montreal (5) · DexCom, Inc. (3) · Elaine Chow (3) · Nanjing First Hospital, Nanjing Medical University (2) · GlySure (1) · Leryn Reynolds (1) · Ningbo No. 1 Hospital (1) · Pusan National University Hospital (1) · Science Consulting in Diabetes (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · University of Campania Luigi Vanvitelli (1) · University of Malaya (1) · University of Wisconsin, Madison (1)
United States (9) · Canada (4) · China (4) · Hong Kong (2) · Germany (1) · India (1) · Italy (1) · Malaysia (1) · South Korea (1)
Mark Christiansen, MD (2) · Andrew Balo (1) · Angela Zanfardino (1) · Elaine Chow (1) · Elaine Chow, PhD, MBChB (1) · Jianhua Ma, MD (1) · Krishna Prasad, MD (1) · Leryn Reynolds, Ph.D. (1) · Ma Jianhua (1) · Norbert Hermanns, Prof. (1) · Remi Rabasa-Lhoret (1)
PMID 29459019, PMID 29663517, PMID 33050728, PMID 33863716, PMID 35574003, PMID 35604794, PMID 36399114, PMID 39869118, PMID 40348338